IBM announces first-ever ‘cloud-based, machine-learning-powered’ Watson for healthcare

IBM today announced that it is the first healthcare software company to build a machine-learned, cloud-based Watson system that can analyze patient data and perform medical diagnoses.

Watson is designed to be a fully integrated, cloud based platform for diagnosing and treating disease, with no separate data or storage for patients.

Watson will be developed by IBM Research and IBM Healthcare Solutions.

“We’re proud to be at the forefront of healthcare, and we think Watson is a game-changer,” said Dr. Daniel Lippmann, vice president of Watson at IBM Research.

“The cloud- and AI-driven revolution is here, and Watson is the next big thing.”

Watson will provide healthcare professionals with the ability to diagnose and manage a variety of complex conditions, from cancer to heart disease.

The software will be built to work with IBM’s IBM Cloud platform, which enables IBM to scale up healthcare services with minimal downtime.

Watson, which was designed to solve a range of problems, will also help medical and business leaders better understand and control the complex challenges facing hospitals, hospitals’ health systems and healthcare providers.

Watson’s capabilities will help healthcare organizations reduce time and cost to treat patients, and reduce the number of doctors needed to treat complex health issues.

Watson has already been deployed in healthcare settings such as hospitals, where it is helping to manage patient visits, manage complex medical care, and administer tests and tests suites.

IBM said that Watson’s cloud-enabled capabilities will open up the ability for healthcare organizations to build and test their own solutions that are easier to deploy and more efficient for them.

Watson can work independently or with other healthcare and business partners, and will support medical research.

Watson may be used for a range, but not all, of the following: diagnosis and treatment of chronic diseases such as cancer, Parkinson’s disease, multiple sclerosis, and other complex diseases; diagnostics and monitoring of patients’ health and quality of life; and managing and managing the data that supports and protects healthcare organizations.

IBM will also leverage Watson to make the patient experience easier.

“Watson is a world-class AI system, and our goal is to create the world’s first cloud-native system for healthcare, to provide healthcare partners with a more agile and secure environment for diagnostics, monitoring, and delivering the best medical care,” said Robert Schuller, IBM vice president and general manager of Watson and IBM’s cloud computing solutions.

“It is important to our healthcare partners to be able to quickly deliver high-quality diagnostics to our patients, without having to invest in additional data centers and systems.”

Watson, developed by the Watson Lab at IBM, is a cloud-centric computing system that is designed for use in healthcare.

It uses machine learning algorithms to understand the human brain, and to perform complex tasks such as analyzing large amounts of data and predicting outcomes.

The Watson system can analyze data from a wide variety of sources, including medical, commercial, and non-medical, and is able to process this information in real-time and provide personalized diagnoses based on the most accurate data.

IBM’s Watson will make use of a wide range of Watson platform and software tools, including IBM Watson Advanced Analytics, IBM Watson Professional Diagnostics, IBM Cloud Computing and IBM Watson Diagnostics.

The healthcare and healthcare industry are rapidly advancing towards a fully connected, cloud and AI future, with the emergence of a number of emerging technologies, including cloud computing, virtualization, artificial intelligence, robotics, artificial-intelligence systems, data analytics, analytics tools and the medical data marketplace.

IBM, a wholly owned subsidiary of IBM Corporation, has more than 30,000 employees worldwide.

IBM is the world leader in research and development of cloud and cloud-focused solutions, with more than 1,300 employees worldwide and a market capitalization of $60 billion.

Watson and the IBM Watson platform are expected to be available for download on November 14.

IBM Watson will support a range with Watson Advanced Technologies, the company’s cloud platform and tool suite for diagnasing and monitoring complex disease conditions.

IBM Health, which is a division of IBM Health Group, is focused on healthcare delivery, health information, diagnostics & support, Watson, Watson Diagnosis and Watson Diagnostic Solutions, IBM Health’s healthcare platform and tools for diagnosis and diagnosis, health care and business intelligence, and healthcare systems.

For more information, please visit: http://www.ibm.com/health/products/whatson-and-health-products-services-and/whats-new-and…